文献速递泌尿生殖腹部MR

无增强MRI监测小(临床T1a)实性肾肿块的充分性

Adequacy of Unenhanced MRI for Surveillance of Small (Clinical T1a) Solid Renal Masses.
PubMed 文献 · AJR Am J Roentgenol · 2021-02-17

本研究纳入36例患者共39个cT1a实性肾肿块,评估无增强T2加权MRI与增强MRI在监测中测量大小和分期的相关性。结果显示两种方法测量值近乎完美相关,观察者间和观察者内一致性极佳,临床分期无差异。作者认为cT1a实性肾肿块MRI随访大小测量无需增强。

要点

  • 无增强T2加权MRI与增强MRI测量cT1a实性肾肿块大小近乎完美相关。
  • 两种方法临床分期无差异,观察者间和观察者内一致性极佳。
  • 作者结论:cT1a实性肾肿块MRI随访大小测量无需增强。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to determine if contrast enhancement is necessary for MRI surveillance of clinical T1a (cT1a) solid renal masses. MATERIALS AND METHODS. With institutional review board approval, 36 patients who underwent two or more contrast-enhanced (CE) MRI examinations (median, four examinations; range, two to 10 examinations) for surveillance of 39 cT1a solid renal masses between 2009 and 2019 (median time between scans, 2 years; range, 1-7 years) were evaluated. Two radiologists independently measured renal mass size and assessed tumor stage in two sessions for baseline and follow-up examinations using T1-weighted nephrographic phase CE-MRI and unenhanced single-shot T2-weighted MRI in mixed order with a 4-week washout period. Comparisons were performed using the Wilcoxon sign-rank test and Pearson correlation. Bland-Altman and intraclass correlation determined interobserver agreement. RESULTS. Mean size ± SD of renal masses on CE-MRI and T2-weighted MRI were 18 ± 5 mm (range, 9-37 mm) and 18 ± 5 mm (range, 9-37 mm) for radiologist 1 and 19 ± 7 mm (range, 10-39 mm) and 19 ± 6 mm (range, 10-39 mm) for radiologist 2 with near perfect correlation (for radiologist 1, β = 0.9897; for radiologist 2, β = 0.9317; p < .001). Interob-server agreement for measurements comparing radiologist 1 and radiologist 2 on CEMRI and T2-weighted MRI and intraobserver agreement for measurements on CE-MRI and T2-weighted MRI were excellent. Mean growth rate of renal masses measured on CE-MRI and T2-weighted MRI were 2 ± 2 mm (range, -5 to 8 mm) and 2 ± 3 mm (range, -3 to 8 mm) for radiologist 1 and 3 ± 5 mm (range, -1 to 18 mm) and 3 ± 6 mm (range, -1 to 24 mm) for radiologist 2 with high correlation (for radiologist 1, β = 0.8313 [p < .001]; for radiologist 2, β = 0.848 [p = .002]). At baseline, all tumors were subjectively cT1a on CE-MRI and T2-weighted MRI (p > .99, intraclass correlation coefficient [ICC] = 1). During follow-up, one mass progressed to T3 on CE-MRI and T2-weighted MRI for radiologist 1 and radiologist 2 (p > .99, ICC = 1). CONCLUSION. In this study, size measurements on unenhanced T2-weighted MRI had near perfect correlation to measurements using CE-MRI in cT1a solid renal masses undergoing surveillance, with high agreement between and within observers. Clinical staging did not differ comparing T2-weighted MRI and CE-MRI, with near perfect agreement. Contrast enhancement is not necessary for follow-up size measurements in cT1a solid renal masses with MRI.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Mawi H, Narine R, Schieda N, et al. Adequacy of Unenhanced MRI for Surveillance of Small (Clinical T1a) Solid Renal Masses. AJR Am J Roentgenol. 2021. PMID: 33594909. doi:10.2214/AJR.20.23458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。